1985–1991[]
|
BETTER LOGO NEEDED |
1991–1997[]
On December 29, 1997, Hoechst (now Sanofi) announced that it would withdraw Seldane from the market following reports that it had fatal interactions with other drugs, with the most common being irregularities in the heartbeat.
| Predecessors: Sanofi-Synthélabo | Aventis (Hoechst | Rhône-Poulenc)
Subsidiaries: Sanofi Pasteur | Sanofi Genzyme | Chattem | Medley | Opella Brands: Discontinued  |